Home » Healthcare » Pharmaceuticals » Laxatives Market

Laxatives Market By Drug Type (Hyperosmotic Laxatives, Bulk-Forming Laxatives, Stool Softeners, Lubricants, Others); By Indication (Chronic Constipation, Irritable Bowel Syndrome (IBS), Others); By End User (Hospitals & Clinics, Research Institutes, Others); By Route of Administration (Oral, Rectal); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Laxatives Market Size 2023	USD 6,869.93 million
Laxatives Market, CAGR	4.72%
Laxatives Market Size 2032	USD 9,937.01 million

Market Overview

The Laxatives Market is projected to grow from USD 6,869.93 million in 2023 to an estimated USD 9,937.01 million by 2032, with a compound annual growth rate (CAGR) of 4.72% from 2024 to 2032. This growth is primarily driven by increasing awareness about digestive health, rising incidences of gastrointestinal disorders, and an aging population more susceptible to constipation and related conditions.

Market drivers include the rising demand for convenient and effective treatments for constipation, coupled with the growing trend towards self-care and the availability of various laxative formulations. Additionally, advancements in product innovation and the introduction of natural and organic laxatives are expected to further boost market growth. However, side effects associated with long-term laxative use and stringent regulatory approvals may pose challenges to market expansion.

Geographically, North America dominates the global laxatives market due to high healthcare awareness, a well-established pharmaceutical industry, and a significant elderly population. Europe follows closely, driven by similar factors. The Asia Pacific region is expected to witness the fastest growth during the forecast period, attributed to increasing healthcare expenditure, rising awareness of gastrointestinal disorders, and a growing demand for over-the-counter medications. Key players in the market include Bayer AG, Abbott Laboratories, GlaxoSmithKline plc, Sanofi S.A., and AstraZeneca, among others.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

One of the primary drivers of the global laxatives market is the increasing prevalence of gastrointestinal (GI) disorders, particularly constipation, irritable bowel syndrome (IBS), and other related conditions. For instance, a substantial portion of the U.S. adult population experiences symptoms of chronic constipation. The modern lifestyle, characterized by poor dietary habits, sedentary routines, and high stress levels, contributes significantly to the rise in GI disorders. As these conditions become more widespread, the demand for effective and accessible treatment options like laxatives grows. Additionally, the growing awareness about the importance of maintaining digestive health has led more individuals to seek over-the-counter (OTC) solutions, further fueling the market’s expansion. For example, surveys conducted by the American Gastroenterological Association have shown an upward trend in the number of people actively seeking information and solutions for digestive health issues. Healthcare professionals increasingly recommend laxatives as part of a comprehensive treatment plan for patients suffering from chronic constipation and related disorders, driving market growth.

Aging Population and Increased Healthcare Spending

The global aging population is another critical driver of the laxatives market. As people age, they are more likely to experience constipation due to a variety of factors, including slower digestion, decreased physical activity, and the use of certain medications that can cause constipation as a side effect. For instance, a significant increase in the global population aged 60 years and above, with projections indicating continued growth in the coming decades. This demographic shift significantly impacts the demand for laxatives, as older adults often require consistent and safe remedies to manage constipation. Moreover, the increased healthcare spending associated with aging populations in developed and developing regions has led to improved access to healthcare services and products, including laxatives. For example, reports from the Organisation for Economic Co-operation and Development (OECD) highlight a trend of rising healthcare expenditure across member countries, with a notable portion allocated to addressing age-related health issues. Governments and healthcare organizations are also emphasizing the importance of addressing age-related health issues, further contributing to the market’s growth. For instance, initiatives by the World Health Organization to promote healthy aging have indirectly supported the growth of markets for products that address common age-related conditions like constipation.

Shift Towards Self-Medication and OTC Products

The trend towards self-medication and the increasing availability of over-the-counter (OTC) laxatives are key factors driving the global laxatives market. Consumers are becoming more proactive in managing their health, with a growing preference for OTC products that offer convenience and immediate relief from symptoms. This shift is particularly evident in urban areas where access to healthcare professionals may be limited or where consumers prefer to avoid the cost and time associated with visiting a doctor for minor health issues. The widespread availability of laxatives in pharmacies, supermarkets, and online platforms has made it easier for consumers to purchase these products without a prescription. Additionally, the marketing efforts of pharmaceutical companies have significantly influenced consumer behavior, making laxatives a common household item for digestive health management. The trend towards self-care is expected to continue, driving the market’s expansion in the coming years.

Product Innovation and Diversification

Innovation in laxative formulations and the diversification of product offerings are crucial drivers of market growth. Pharmaceutical companies are investing in research and development to create new and improved laxatives that are more effective, have fewer side effects, and are easier to use. For instance, the development of natural and organic laxatives has gained popularity among consumers who prefer more natural health solutions. These products are often marketed as gentler on the digestive system and free from synthetic chemicals, appealing to health-conscious consumers. Additionally, innovations in dosage forms, such as liquid, chewable, and powder formulations, have made laxatives more accessible and user-friendly, catering to different consumer preferences. The introduction of laxatives that address specific needs, such as those suitable for pregnant women, children, or individuals with specific dietary restrictions, has also expanded the market’s reach. This ongoing product diversification not only attracts a broader consumer base but also encourages repeat purchases, driving sustained market growth.

Market Trends

Growing Demand for Natural and Organic Laxatives

A significant trend in the global laxatives market is the increasing demand for natural and organic laxatives. Consumers are becoming more health-conscious and seeking alternatives to conventional pharmaceutical products that they perceive as safer and gentler on the body. This shift is driven by the broader trend towards natural health solutions and clean-label products. Natural laxatives often include ingredients like psyllium husk, aloe vera, flaxseeds, and prunes. They are gaining popularity due to their perceived health benefits and lower risk of side effects. Government surveys have shown a growing consumer preference for natural and organic products across various health categories, including digestive health. High authority surveys conducted by market research firms indicate that a substantial portion of consumers are willing to pay a premium for natural and organic laxatives. This trend is prompting pharmaceutical companies to innovate and expand their product portfolios to include more natural and organic options. Many companies are reformulating existing products or launching new product lines to meet this demand. The trend is particularly strong among younger consumers and in developed markets where health awareness is high.

Technological Advancements and Product Innovation

Technological advancements and ongoing product innovation are shaping the landscape of the global laxatives market. Manufacturers are focusing on developing new formulations and delivery methods that enhance the efficacy and convenience of laxative products. For instance, the introduction of chewable tablets, liquid formulations, and flavored powders has made laxatives more palatable and easier to consume. Government health agencies have reported an increase in research and development activities related to laxative formulations. High authority surveys of healthcare professionals indicate a growing interest in prescribing newer, more targeted laxative formulations. Advancements in drug delivery technologies are enabling the development of targeted-release laxatives that act specifically in certain parts of the digestive tract. Another key innovation trend is the integration of probiotics into laxative formulations, which not only help alleviate constipation but also promote overall gut health. Market research firms have noted a significant uptick in patent filings related to novel laxative formulations and delivery methods, indicating strong innovation activity in the sector.

Market Restraints and Challenges

Side Effects and Long-Term Health Risks

One of the primary restraints in the global laxatives market is the potential for side effects and long-term health risks associated with frequent or inappropriate use of laxatives. Government surveys have found that a significant portion of laxative users experience adverse effects like abdominal pain, bloating, and diarrhea. Long-term use has been linked to more serious complications, including electrolyte imbalances and damage to the colon. Medical authorities have expressed concern about laxative dependency, particularly among certain demographic groups. For instance, higher rates of laxative abuse among young women and older adults. The growing awareness of these risks is causing some consumers to seek alternative treatments for constipation. Healthcare professionals are increasingly recommending lifestyle changes and non-pharmacological interventions as first-line treatments. This shift in medical guidance could potentially limit growth in the over-the-counter laxative market.

Regulatory Challenges and Product Approval

Regulatory challenges represent another significant restraint in the global laxatives market. Health authorities worldwide have implemented stringent regulations on laxative products, making the development and approval process complex and time-consuming. Government agencies require extensive clinical trials and safety data before approving new laxative formulations. Recent surveys of pharmaceutical companies indicate that the time and cost associated with bringing new laxative products to market have increased substantially over the past decade. Regulatory bodies have also imposed stricter labeling requirements, mandating clear warnings about potential side effects and proper usage. In some regions, certain types of stimulant laxatives have faced restrictions or reclassification due to safety concerns. Additionally, there’s growing scrutiny on the marketing practices for laxative products, with authorities cracking down on unsubstantiated claims. These regulatory hurdles can delay product launches and increase development costs, potentially deterring smaller companies from entering the market and limiting innovation in the sector.

Market Segmentation Analysis

By Drug Type

Hyperosmotic laxatives like polyethylene glycol and lactulose are widely used for acute constipation due to their effectiveness in drawing water into the intestines. For instance, a government health survey found that over half of adults who used laxatives in the past year chose osmotic types. Bulk-forming laxatives such as psyllium are popular for chronic constipation management, with a national consumer poll indicating nearly two-thirds of regular laxative users prefer natural, fiber-based options. Stool softeners like docusate sodium are favored for gentle relief, especially among pregnant women and the elderly. A large-scale study by a gastroenterology association revealed stool softeners were the top choice for over one-third of older adults using laxatives. Lubricant laxatives such as mineral oil are declining in use due to safety concerns, with medical board data showing prescriptions have halved in recent years. The “Others” category includes newer formulations like stimulant laxatives, which a pharmacy benefit survey found are increasingly used as second-line treatments.

By Indications

Chronic constipation is a major driver for the laxatives market. A national health and nutrition examination survey found that nearly one in six adults experiences chronic constipation, with over half seeking treatment. Irritable bowel syndrome (IBS), particularly IBS with constipation (IBS-C), significantly impacts the market. A large-scale patient registry study revealed that about one-third of IBS patients have the constipation-predominant subtype and regularly use laxatives. Growing awareness of IBS is bolstering this segment, with a public health campaign evaluation showing a substantial increase in patients discussing IBS symptoms with their doctors. Other indications like opioid-induced constipation are contributing to market demand. A comprehensive pain management survey indicated that nearly half of long-term opioid users experience constipation, with many requiring specialized laxative treatments. Additionally, a geriatric health assessment found that constipation linked to specific medical conditions affects a significant portion of older adults, driving demand for targeted laxative therapies.

Segments

Based on Drug Type

Hyperosmotic Laxatives
Bulk-Forming Laxatives
Stool Softeners
Lubricants
Others

Based on Indication

Chronic Constipation
Irritable Bowel Syndrome (IBS)
Others

Based on End User

Hospitals & Clinics
Research Institutes
Others

Based on Route of Administration

Oral
Rectal

Based on Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

Regional Analysis

North America (35%):

North America holds the largest share of the global laxatives market, accounting for approximately 35% of the total market revenue in 2023. This dominance is primarily due to the high prevalence of gastrointestinal disorders, a significant elderly population, and well-established healthcare systems. According to a large-scale national survey conducted by the National Institutes of Health, nearly two out of three Americans experience gastrointestinal symptoms, with constipation being one of the most common complaints. The United States is the largest contributor within the region, driven by widespread awareness of digestive health and a strong demand for over-the-counter (OTC) laxatives. The constipation-related healthcare visits and hospitalizations have increased substantially over the past decade, further highlighting the growing market for laxative products in North America.

Europe (28%):

Europe is the second-largest market for laxatives, with a market share of around 28% in 2023. The region benefits from a high level of healthcare awareness, a robust pharmaceutical industry, and a significant elderly population, particularly in countries like Germany, France, and the United Kingdom. A comprehensive European digestive health survey revealed that a substantial portion of the population regularly experiences constipation, with many individuals relying on laxatives for relief. The demand for laxatives in Europe is also driven by the increasing incidence of lifestyle-related gastrointestinal disorders and the growing preference for natural and organic products. The European Medicines Agency has reported a rise in applications for new laxative formulations, indicating ongoing innovation in the market. Furthermore, government initiatives to improve healthcare access and rising consumer health consciousness are expected to sustain market growth in this region.

Key players

Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Ireland)
Sanofi (France)
Pfizer Inc. (U.S.)
GlaxoSmithKline plc (U.K.)
Novartis AG (Switzerland)
Merck & Co., Inc. (U.S.)
AstraZeneca (U.K.)
Johnson & Johnson Private Limited (U.S.)
Hikma Pharmaceuticals PLC (U.K.)
Reddy’s Laboratories Ltd. (India)
Fresenius Kabi AG (Germany)

Competitive Analysis

The global laxatives market is highly competitive, with several key players vying for market share through innovation, strategic partnerships, and extensive product portfolios. Companies like Hoffmann-La Roche, Pfizer, and Novartis leverage their robust research and development capabilities to introduce new and effective laxative formulations. Meanwhile, generics giants such as Mylan N.V. and Teva Pharmaceutical Industries dominate the market with cost-effective products that appeal to a broad consumer base. GlaxoSmithKline and Sanofi maintain strong positions through well-established brands and extensive distribution networks across key regions. Additionally, emerging markets see significant contributions from companies like Dr. Reddy’s Laboratories and Hikma Pharmaceuticals, which focus on affordability and accessibility. The presence of these diverse players ensures a dynamic market environment, with ongoing competition driving innovation and expansion across global regions.

Recent Developments

In January 2023, Sanofi launched Dulcolax Liquid Laxative in the U.S. market, expanding its over-the-counter laxative portfolio.
In July 2022, GSK completed the demerger of its consumer healthcare business, which includes laxative products like Dulcolax, into a separate company called Haleon.
In February 2023, Fresenius Kabi launched Stimufend (pegfilgrastim-fpgk), a biosimilar used to reduce the risk of infection in patients receiving myelosuppressive anti-cancer drugs. While not a laxative, this launch demonstrates the company’s ongoing commitment to expanding its pharmaceutical portfolio.
In February 2024, Hikma reported strong performance in 2023 and a positive outlook for 2024, indicating continued growth in its pharmaceutical business, which includes laxative products.

Market Concentration and Characteristics

The global laxatives market is moderately concentrated, with a mix of large multinational pharmaceutical companies and regional players contributing to the market landscape. The market is characterized by a high level of product differentiation, with a wide range of formulations available, including hyperosmotic, bulk-forming, stool softeners, and lubricant laxatives. Leading companies, such as Pfizer, Sanofi, and Novartis, dominate the market with extensive product portfolios, robust research and development capabilities, and strong global distribution networks. However, the presence of numerous generic manufacturers, particularly in emerging markets, adds a competitive edge to the market, driving down prices and increasing accessibility. The market also exhibits significant innovation, with companies continually developing new products to meet consumer demand for more effective, safer, and natural laxative options. This dynamic environment fosters both competition and collaboration, as companies seek to expand their market share and respond to evolving consumer preferences.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Report Coverage

The research report offers an in-depth analysis based on Drug Type, Indication, End User, Route of Administration and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The global laxatives market is expected to continue its robust growth, driven by rising incidences of gastrointestinal disorders and an aging population. The market is projected to expand at a compound annual growth rate (CAGR) of approximately 5.22% from 2024 to 2032.
Consumer preference for natural and organic laxatives will increase, influencing product development and market strategies. Companies will likely invest more in developing natural formulations to cater to health-conscious consumers.
Innovation in drug delivery technologies will enhance the efficacy and convenience of laxative products. Expect advancements such as targeted-release and combination therapies to become more prevalent.
Emerging markets in Asia Pacific and Latin America will see significant growth due to increasing healthcare access and rising awareness of gastrointestinal health. These regions will become key revenue drivers for the global laxatives market.
Stricter regulatory standards will shape the market landscape, with a focus on product safety and transparency. Companies will need to navigate evolving regulations to ensure compliance and market access.
The preference for over-the-counter (OTC) laxatives will continue to rise as consumers seek convenient and immediate relief options. OTC sales are expected to drive significant market growth in both developed and developing regions.
New formulations and delivery methods, such as chewable tablets and flavored powders, will gain popularity. These innovations aim to improve patient compliance and satisfaction.
Growing awareness and education about gastrointestinal health will drive demand for laxative products. Educational campaigns and health initiatives will contribute to increased market penetration.
Personalized medicine approaches will gain traction, with companies developing tailored laxative solutions based on individual patient needs and preferences. This trend will enhance treatment effectiveness and patient outcomes.
The market will remain competitive with ongoing consolidation and strategic partnerships among key players. Collaboration and mergers will likely intensify as companies seek to enhance their market presence and expand product offerings.

CHAPTER NO. 1 : INTRODUCTION 19
1.1.1. Report Description 19
Purpose of the Report 19
USP & Key Offerings 19
1.1.2. Key Benefits for Stakeholders 19
1.1.3. Target Audience 20
1.1.4. Report Scope 20
CHAPTER NO. 2 : EXECUTIVE SUMMARY 21
2.1. Laxatives Market Snapshot 21
2.1.1. Global Laxatives Market, 2018 – 2032 (USD Million) 22
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23
3.1. Russia-Ukraine and Israel-Palestine War Impacts 23
CHAPTER NO. 4 : LAXATIVES MARKET – INDUSTRY ANALYSIS 24
4.1. Introduction 24
4.2. Market Drivers 25
4.2.1. Driving Factor 1 Analysis 25
4.2.2. Driving Factor 2 Analysis 26
4.3. Market Restraints 27
4.3.1. Restraining Factor Analysis 27
4.4. Market Opportunities 28
4.4.1. Market Opportunity Analysis 28
4.5. Porter’s Five Forces Analysis 29
CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 30
5.1. Company Market Share Analysis – 2023 30
5.1.1. Global Laxatives Market: Company Market Share, by Volume, 2023 30
5.1.2. Global Laxatives Market: Company Market Share, by Revenue, 2023 31
5.1.3. Global Laxatives Market: Top 6 Company Market Share, by Revenue, 2023 31
5.1.4. Global Laxatives Market: Top 3 Company Market Share, by Revenue, 2023 32
5.2. Global Laxatives Market Company Revenue Market Share, 2023 33
5.3. Company Assessment Metrics, 2023 34
5.3.1. Stars 34
5.3.2. Emerging Leaders 34
5.3.3. Pervasive Players 34
5.3.4. Participants 34
5.4. Start-ups /SMEs Assessment Metrics, 2023 34
5.4.1. Progressive Companies 34
5.4.2. Responsive Companies 34
5.4.3. Dynamic Companies 34
5.4.4. Starting Blocks 34
5.5. Strategic Developments 35
5.5.1. Acquisitions & Mergers 35
New Product Launch 35
Global Expansion 35
5.6. Key Players Product Matrix 36
CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 37
6.1. PESTEL 37
6.1.1. Political Factors 37
6.1.2. Economic Factors 37
6.1.3. Social Factors 37
6.1.4. Technological Factors 37
6.1.5. Environmental Factors 37
6.1.6. Legal Factors 37
6.2. Adjacent Market Analysis 37
CHAPTER NO. 7 : LAXATIVES MARKET – BY DRUG TYPE SEGMENT ANALYSIS 38
7.1. Laxatives Market Overview, by Drug Type Segment 38
7.1.1. Laxatives Market Revenue Share, By Drug Type, 2023 & 2032 39
7.1.2. Laxatives Market Attractiveness Analysis, By Drug Type 40
7.1.3. Incremental Revenue Growth Opportunity, by Drug Type, 2024 – 2032 40
7.1.4. Laxatives Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 41
7.2. Hyperosmotic 42
7.3. Bulk-Forming 43
7.4. Stool Softeners 44
7.5. Lubricants 45
7.6. Others 46
CHAPTER NO. 8 : LAXATIVES MARKET – BY INDICATION SEGMENT ANALYSIS 47
8.1. Laxatives Market Overview, by Indication Segment 47
8.1.1. Laxatives Market Revenue Share, By Indication, 2023 & 2032 48
8.1.2. Laxatives Market Attractiveness Analysis, By Indication 49
8.1.3. Incremental Revenue Growth Opportunity, by Indication, 2024 – 2032 49
8.1.4. Laxatives Market Revenue, By Indication, 2018, 2023, 2027 & 2032 50
8.2. Chronic Constipation 51
8.3. Irritable Bowel Syndrome 52
8.4. Others 53
CHAPTER NO. 9 : LAXATIVES MARKET – BY END-USER SEGMENT ANALYSIS 54
9.1. Laxatives Market Overview, by End-user Segment 54
9.1.1. Laxatives Market Revenue Share, By End-user, 2023 & 2032 55
9.1.2. Laxatives Market Attractiveness Analysis, By End-user 56
9.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 56
9.1.4. Laxatives Market Revenue, By End-user, 2018, 2023, 2027 & 2032 57
9.2. Hospitals & Clinics 58
9.3. Research Institutes 59
9.4. Others 60
CHAPTER NO. 10 : LAXATIVES MARKET – BY ROUTE OF ADMINISTRATION SEGMENT ANALYSIS 61
10.1. Laxatives Market Overview, by Route of Administration Segment 61
10.1.1. Laxatives Market Revenue Share, By Route of Administration, 2023 & 2032 62
10.1.2. Laxatives Market Attractiveness Analysis, By Route of Administration 63
10.1.3. Incremental Revenue Growth Opportunity, by Route of Administration, 2024 – 2032 63
10.1.4. Laxatives Market Revenue, By Route of Administration, 2018, 2023, 2027 & 2032 64
10.2. Oral 65
10.3. Rectal 66
CHAPTER NO. 11 : LAXATIVES MARKET – GLOBAL ANALYSIS 67
11.1. Drug Type 67
11.1.1. Global Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 67
11.2. Global Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 67
11.3. Indication 68
11.3.1. Global Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 68
11.3.2. Global Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 68
11.4. End-user 69
11.4.1. Global Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 69
11.4.2. Global Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 69
11.5. Route of Administration 70
11.5.1. Global Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 70
11.5.2. Global Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 70
CHAPTER NO. 12 : LAXATIVES MARKET – NORTH AMERICA 71
12.1. North America 71
12.1.1. Key Highlights 71
12.1.2. North America Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 72
12.1.3. North America Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 73
12.1.4. North America Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 74
12.1.5. North America Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 75
12.1.6. North America Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 76
12.2. U.S. 77
12.3. Canada 77
12.4. Mexico 77
CHAPTER NO. 13 : LAXATIVES MARKET – EUROPE 78
13.1. Europe 78
13.1.1. Key Highlights 78
13.1.2. Europe Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 79
13.1.3. Europe Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 80
13.1.4. Europe Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 81
13.1.5. Europe Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 82
13.1.6. Europe Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 83
13.2. UK 84
13.3. France 84
13.4. Germany 84
13.5. Italy 84
13.6. Spain 84
13.7. Russia 84
13.8. Belgium 84
13.9. Netherland 84
13.10. Austria 84
13.11. Sweden 84
13.12. Poland 84
13.13. Denmark 84
13.14. Switzerland 84
13.15. Rest of Europe 84
CHAPTER NO. 14 : LAXATIVES MARKET – ASIA PACIFIC 85
14.1. Asia Pacific 85
14.1.1. Key Highlights 85
14.1.2. Asia Pacific Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 86
14.1.3. Asia Pacific Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 87
14.1.4. Asia Pacific Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 88
14.1.5. Asia Pacific Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 89
14.1.6. Asia Pacific Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 90
14.2. China 91
14.3. Japan 91
14.4. South Korea 91
14.5. India 91
14.6. Australia 91
14.7. Thailand 91
14.8. Indonesia 91
14.9. Vietnam 91
14.10. Malaysia 91
14.11. Philippines 91
14.12. Taiwan 91
14.13. Rest of Asia Pacific 91
CHAPTER NO. 15 : LAXATIVES MARKET – LATIN AMERICA 92
15.1. Latin America 92
15.1.1. Key Highlights 92
15.1.2. Latin America Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 93
15.1.3. Latin America Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 94
15.1.4. Latin America Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 95
15.1.5. Latin America Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 96
15.1.6. Latin America Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 97
15.2. Brazil 98
15.3. Argentina 98
15.4. Peru 98
15.5. Chile 98
15.6. Colombia 98
15.7. Rest of Latin America 98
CHAPTER NO. 16 : LAXATIVES MARKET – MIDDLE EAST 99
16.1. Middle East 99
16.1.1. Key Highlights 99
16.1.2. Middle East Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 100
16.1.3. Middle East Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 101
16.1.4. Middle East Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 102
16.1.5. Middle East Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 103
16.1.6. Middle East Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 104
16.2. UAE 105
16.3. KSA 105
16.4. Israel 105
16.5. Turkey 105
16.6. Iran 105
16.7. Rest of Middle East 105
CHAPTER NO. 17 : LAXATIVES MARKET – AFRICA 106
17.1. Africa 106
17.1.1. Key Highlights 106
17.1.2. Africa Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 107
17.1.3. Africa Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 108
17.1.4. Africa Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 109
17.1.5. Africa Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 110
17.1.6. Africa Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 111
17.2. Egypt 112
17.3. Nigeria 112
17.4. Algeria 112
17.5. Morocco 112
17.6. Rest of Africa 112
CHAPTER NO. 18 : COMPANY PROFILES 113
18.1. Hoffmann-La Roche Ltd. 113
18.1.1. Company Overview 113
18.1.2. Product Portfolio 113
18.1.3. Swot Analysis 113
18.1.4. Business Strategy 114
18.1.5. Financial Overview 114
18.2. Mylan N.V. (U.S.) 115
18.3. Teva Pharmaceutical Industries Ltd. (Ireland) 115
18.4. Sanofi (France) 115
18.5. Pfizer Inc. (U.S.) 115
18.6. GlaxoSmithKline plc (U.K.) 115
18.7. Novartis AG (Switzerland) 115
18.8. Merck & Co., Inc. (U.S.) 115
18.9. AstraZeneca (U.K.) 115
18.10. Johnson & Johnson Private Limited (U.S.) 115
18.11. Hikma Pharmaceuticals PLC (U.K.) 115
18.12. Reddy’s Laboratories Ltd. (India) 115
18.13. Fresenius Kabi AG (Germany) 115
CHAPTER NO. 19 : RESEARCH METHODOLOGY 116
19.1. Research Methodology 116
19.1.1. Phase I – Secondary Research 117
19.1.2. Phase II – Data Modeling 117
Company Share Analysis Model 118
Revenue Based Modeling 118
19.1.3. Phase III – Primary Research 119
19.1.4. Research Limitations 120
Assumptions 120

List of Figures
FIG NO. 1. Global Laxatives Market Revenue, 2018 – 2032 (USD Million) 23
FIG NO. 2. Porter’s Five Forces Analysis for Global Laxatives Market 30
FIG NO. 3. Company Share Analysis, 2023 31
FIG NO. 4. Company Share Analysis, 2023 32
FIG NO. 5. Company Share Analysis, 2023 32
FIG NO. 6. Company Share Analysis, 2023 33
FIG NO. 7. Laxatives Market – Company Revenue Market Share, 2023 34
FIG NO. 8. Laxatives Market Revenue Share, By Drug Type, 2023 & 2032 40
FIG NO. 9. Market Attractiveness Analysis, By Drug Type 41
FIG NO. 10. Incremental Revenue Growth Opportunity by Drug Type, 2024 – 2032 41
FIG NO. 11. Laxatives Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 42
FIG NO. 12. Global Laxatives Market for Hyperosmotic, Revenue (USD Million) 2018 – 2032 43
FIG NO. 13. Global Laxatives Market for Bulk-Forming, Revenue (USD Million) 2018 – 2032 44
FIG NO. 14. Global Laxatives Market for Stool Softeners, Revenue (USD Million) 2018 – 2032 45
FIG NO. 15. Global Laxatives Market for Lubricants, Revenue (USD Million) 2018 – 2032 46
FIG NO. 16. Global Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 47
FIG NO. 17. Laxatives Market Revenue Share, By Indication, 2023 & 2032 49
FIG NO. 18. Market Attractiveness Analysis, By Indication 50
FIG NO. 19. Incremental Revenue Growth Opportunity by Indication, 2024 – 2032 50
FIG NO. 20. Laxatives Market Revenue, By Indication, 2018, 2023, 2027 & 2032 51
FIG NO. 21. Global Laxatives Market for Chronic Constipation, Revenue (USD Million) 2018 – 2032 52
FIG NO. 22. Global Laxatives Market for Irritable Bowel Syndrome, Revenue (USD Million) 2018 – 2032 53
FIG NO. 23. Global Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 54
FIG NO. 24. Laxatives Market Revenue Share, By End-user, 2023 & 2032 56
FIG NO. 25. Market Attractiveness Analysis, By End-user 57
FIG NO. 26. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 57
FIG NO. 27. Laxatives Market Revenue, By End-user, 2018, 2023, 2027 & 2032 58
FIG NO. 28. Global Laxatives Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032 59
FIG NO. 29. Global Laxatives Market for Research Institutes, Revenue (USD Million) 2018 – 2032 60
FIG NO. 30. Global Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 61
FIG NO. 31. Laxatives Market Revenue Share, By Route of Administration, 2023 & 2032 63
FIG NO. 32. Market Attractiveness Analysis, By Route of Administration 64
FIG NO. 33. Incremental Revenue Growth Opportunity by Route of Administration, 2024 – 2032 64
FIG NO. 34. Laxatives Market Revenue, By Route of Administration, 2018, 2023, 2027 & 2032 65
FIG NO. 35. Global Laxatives Market for Oral, Revenue (USD Million) 2018 – 2032 66
FIG NO. 36. Global Laxatives Market for Rectal, Revenue (USD Million) 2018 – 2032 67
FIG NO. 37. North America Laxatives Market Revenue, 2018 – 2032 (USD Million) 72
FIG NO. 38. Europe Laxatives Market Revenue, 2018 – 2032 (USD Million) 79
FIG NO. 39. Asia Pacific Laxatives Market Revenue, 2018 – 2032 (USD Million) 86
FIG NO. 40. Latin America Laxatives Market Revenue, 2018 – 2032 (USD Million) 93
FIG NO. 41. Middle East Laxatives Market Revenue, 2018 – 2032 (USD Million) 100
FIG NO. 42. Africa Laxatives Market Revenue, 2018 – 2032 (USD Million) 107
FIG NO. 43. Research Methodology – Detailed View 117
FIG NO. 44. Research Methodology 118

List of Tables
TABLE NO. 1. : Global Laxatives Market: Snapshot 22
TABLE NO. 2. : Drivers for the Laxatives Market: Impact Analysis 26
TABLE NO. 3. : Restraints for the Laxatives Market: Impact Analysis 28
TABLE NO. 4. : Global Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 68
TABLE NO. 5. : Global Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 68
TABLE NO. 6. : Global Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 69
TABLE NO. 7. : Global Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 69
TABLE NO. 8. : Global Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 70
TABLE NO. 9. : Global Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 70
TABLE NO. 10. : Global Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 71
TABLE NO. 11. : Global Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 71
TABLE NO. 12. : North America Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 73
TABLE NO. 13. : North America Laxatives Market Revenue, By Country, 2024 – 2032 (USD Million) 73
TABLE NO. 14. : North America Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 74
TABLE NO. 15. : North America Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 74
TABLE NO. 16. : North America Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 75
TABLE NO. 17. : North America Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 75
TABLE NO. 18. : North America Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 76
TABLE NO. 19. : North America Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 76
TABLE NO. 20. : North America Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 77
TABLE NO. 21. : North America Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 77
TABLE NO. 22. : Europe Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 80
TABLE NO. 23. : Europe Laxatives Market Revenue, By Country, 2024 – 2032 (USD Million) 80
TABLE NO. 24. : Europe Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 81
TABLE NO. 25. : Europe Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 81
TABLE NO. 26. : Europe Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 82
TABLE NO. 27. : Europe Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 82
TABLE NO. 28. : Europe Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 83
TABLE NO. 29. : Europe Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 83
TABLE NO. 30. : Europe Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 84
TABLE NO. 31. : Europe Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 84
TABLE NO. 32. : Asia Pacific Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 87
TABLE NO. 33. : Asia Pacific Laxatives Market Revenue, By Country, 2024 – 2032 (USD Million) 87
TABLE NO. 34. : Asia Pacific Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 88
TABLE NO. 35. : Asia Pacific Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 88
TABLE NO. 36. : Asia Pacific Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 89
TABLE NO. 37. : Asia Pacific Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 89
TABLE NO. 38. : Asia Pacific Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 90
TABLE NO. 39. : Asia Pacific Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 90
TABLE NO. 40. : Asia Pacific Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 91
TABLE NO. 41. : Asia Pacific Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 91
TABLE NO. 42. : Latin America Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 94
TABLE NO. 43. : Latin America Laxatives Market Revenue, By Country, 2024 – 2032 (USD Million) 94
TABLE NO. 44. : Latin America Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 95
TABLE NO. 45. : Latin America Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 95
TABLE NO. 46. : Latin America Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 96
TABLE NO. 47. : Latin America Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 96
TABLE NO. 48. : Latin America Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 97
TABLE NO. 49. : Latin America Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 97
TABLE NO. 50. : Latin America Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 98
TABLE NO. 51. : Latin America Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 98
TABLE NO. 52. : Middle East Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 101
TABLE NO. 53. : Middle East Laxatives Market Revenue, By Country, 2024 – 2032 (USD Million) 101
TABLE NO. 54. : Middle East Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 102
TABLE NO. 55. : Middle East Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 102
TABLE NO. 56. : Middle East Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 103
TABLE NO. 57. : Middle East Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 103
TABLE NO. 58. : Middle East Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 104
TABLE NO. 59. : Middle East Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 104
TABLE NO. 60. : Middle East Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 105
TABLE NO. 61. : Middle East Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 105
TABLE NO. 62. : Africa Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 108
TABLE NO. 63. : Africa Laxatives Market Revenue, By Country, 2024 – 2032 (USD Million) 108
TABLE NO. 64. : Africa Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 109
TABLE NO. 65. : Africa Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 109
TABLE NO. 66. : Africa Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 110
TABLE NO. 67. : Africa Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 110
TABLE NO. 68. : Africa Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 111
TABLE NO. 69. : Africa Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 111
TABLE NO. 70. : Africa Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 112
TABLE NO. 71. : Africa Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 112

Frequently Asked Questions

What is the projected growth rate of the global laxatives market?

The Laxatives Market is projected to grow from USD 6,869.93 million in 2023 to an estimated USD 9,937.01 million by 2032, with a compound annual growth rate (CAGR) of 4.72% from 2024 to 2032.

What factors are driving the growth of the laxatives market?

Market growth is driven by increasing awareness of gastrointestinal health, the rising geriatric population, and the growing prevalence of constipation-related disorders, along with a trend towards self-care and product innovation.

Which region is expected to witness the fastest growth in the laxatives market?

The Asia Pacific region is anticipated to experience the fastest growth, due to rising healthcare expenditure, increasing awareness of gastrointestinal disorders, and a growing demand for over-the-counter medications.

What challenges might affect the laxatives market?

Challenges include potential side effects associated with long-term laxative use and stringent regulatory requirements for product approval, which could impact market expansion.

Who are the key players in the global laxatives market?

Key players in the market include Bayer AG, Abbott Laboratories, GlaxoSmithKline plc, Sanofi S.A., and AstraZeneca, among others, who are leading innovation and market development.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –